Links to articles in the current and previous 2 issues of this bulletin are displayed below.
To receive email notifications about new issues of this bulletin, please email richard.fallis@healthcarelibrary.qub.ac.uk to subscribe.
Adrenocortical carcinoma: a practical guide for clinicians
Age and sex differences in efficacy of treatments for type 2 diabetes: a network meta-analysis
Challenges in care provision for children and adolescents with differences of sex development
The cost of adrenal insufficiency in England—analysis of NHS HES data
Definition and diagnostic criteria of clinical obesity
Diabetes can impact cellular immunity in solid tumors
Ghrelin: an emerging therapy for heart failure
Klinefelter syndrome: a review
The metabolic programming of pubertal onset
A randomized trial of automated insulin delivery in type 2 diabetes
The role of the hypothalamic–pituitary–thyroid axis in thyroid cancer
Clinical Endocrinology (Apr-Jun); JAMA (Mar); JAMA Internal Medicine (Apr); Lancet, The (Mar); Lancet Diabetes and Endocrinology, The (Mar-May); NEJM (May); Trends in Immunology (Apr)
Biomarkers and diagnostic thresholds for congenital hyperinsulinism
Dissection of type 2 diabetes: a genetic perspective
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes
Elacestrant for treating oestrogen receptor-positive HER2-negative advanced breast cancer with an ESR1 mutation after endocrine treatment (new NICE guideline TA1036)
Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial
Glucagon‐like peptide 1 (GLP‐1) receptor agonists for people with chronic kidney disease and diabetes (new Cochrane intervention review)
Hypothalamic obesity: from basic mechanisms to clinical perspectives
Is it time to revisit the recommendations for initiation of menopausal hormone therapy?
Managing hypoglycaemia in patients with insulinoma
Outcomes after medical treatment for primary aldosteronism
PEG precipitation to detect macro-TSH in clinical practice: a systematic review
Selpercatinib for advanced thyroid cancer with RET alterations after treatment with a targeted cancer drug in people 12 years and over (new NICE guideline TA1038)
Setmelanotide in patients aged 2–5 years with rare MC4R pathway-associated obesity (VENTURE)
The use of prednisolone 2.5 mg daily during Ramadan fasting in patients with adrenal insufficiency
Clinical Endocrinology (Feb-Mar); Cochrane Library (Jan-Feb); Lancet Diabetes and Endocrinology, The (Jan-Feb); NICE website (Jan-Feb)
Aberrant hormone receptors regulate a wide spectrum of endocrine tumors
Assessment of testicular function in boys and adolescents
Biomarkers in congenital adrenal hyperplasia
Biomarkers to inform the management of polycystic ovary syndrome: a review of systematic reviews
Developing oral chronotherapy for cortisol replacement in congenital adrenal hyperplasia
The effectiveness of delivery modalities of non-pharmacological diabetes prevention programs
Long-term health consequences of congenital adrenal hyperplasia
Male hypogonadism: pathogenesis, diagnosis, and management
Preventing diabetes complications
SARS-CoV-2 infection and new-onset type 2 diabetes among pediatric patients, 2020-2022
Sodium–glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19
Clinical Endocrinology (Oct-Nov); Diabetes and Metabolic Syndrome: Clinical Research and Reviews (Sep-Oct); Diabetology (Sep); Internal Medicine Journal (Aug); JAMA Network Open (Oct); Lancet Diabetes and Endocrinology, The (Oct-Nov); Primary Care Diabetes (Aug-Oct)
The Healthcare Library cannot guarantee the correctness or completeness of the information in these bulletins. The information is subject to change and we cannot guarantee it will remain up-to-date. It is your responsibility to check the accuracy and validity of the information. These bulletins are the property of the Healthcare Library; please credit us if re-using or distributing content from them.